Reliability and validity of smartphone cognitive testing for frontotemporal lobar degeneration

JAMA Network Open

2024-04-01

(Press-News.org) About The Study: The findings of this study suggest that smartphones could offer a feasible, reliable, valid, and scalable solution for remote evaluations of frontotemporal lobar degeneration, a neurodegenerative pathology causing early-onset dementia syndromes, and may improve early detection. Smartphone assessments should be considered as a complementary approach to traditional in-person trial designs. Future research should validate these results in diverse populations and evaluate the utility of these tests for longitudinal monitoring.

Authors: Adam M. Staffaroni, Ph.D., of the University of California, San Francisco, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2024.4266)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.4266?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040124

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

App may pave way to treatments for no. 1 dementia in under-60s

2024-04-01

UCSF-led research shows smartphone cognitive testing is comparable to gold-standard methods; may detect FTD in gene carriers before symptoms start. A smartphone app could enable greater participation in clinical trials for people with frontotemporal dementia (FTD), a devastating neurological disorder that often manifests in midlife. Research into the condition has been hampered by problems with early diagnosis and difficulty tracking how people are responding to treatments that are only likely to be effective at the early stages ...

Exposure to polybrominated diphenyl ethers and risk of all-cause and cause-specific mortality

2024-04-01

About The Study: In this nationally representative cohort study, polybrominated diphenyl ether (PBDE) exposure was significantly associated with an increased risk of cancer mortality. Since the 1970s, PBDEs have been used as flame retardants in a wide array of consumer products, such as building materials, furnishings, and electronics. Further studies are needed to replicate the findings and determine the underlying mechanisms. Authors: Wei Bao, M.D., Ph.D., and Buyun Liu, M.D., Ph.D., of the University of Science and Technology of China in Hefei, Anhui, China, ...

Binge drinking among sports gamblers

2024-04-01

About The Study: In this survey study, binge drinking in both men and women was reported at greater frequency among sports wagering individuals compared with nongamblers and non–sports gamblers. Authors: Joshua B. Grubbs, Ph.D., of the University of New Mexico in Albuquerque, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.5473) Editor’s Note: Please see the ...

New satellite dataset sheds light on Earth's plant growth

2024-04-01

In the field of environmental and climate science, researchers have developed the Comprehensive Mechanistic Light Response (CMLR) gross primary production (GPP) dataset. Derived from the TROPOMI satellite's solar-induced chlorophyll fluorescence (SIF) observations, this global dataset offers unprecedented insights into Earth's GPP, the process through which plants convert carbon dioxide and sunlight into essential resources. Gross Primary Production (GPP), the process through which plants convert carbon dioxide and sunlight into glucose and oxygen, is the Earth's largest carbon flux. Accurate quantification ...

Machine learning provides a new picture of the great gray owl

2024-04-01

The great gray owl has long been thought of as a sentinel of the Alaska wilderness, keeping watch over snow-laden forests as far north as the Brooks Range, well away from human populations. In a study published last week with Nature Scientific Reports, a team of University of Alaska Fairbanks researchers upends the notion that the iconic bird — known as the phantom of the North — lives far from cities, towns and other markers of human density. “We like to think of our wildlife, especially in Alaska, as existing in pristine wilderness untouched by humans,” said Falk Huettmann, professor ...

Pilot study shows ketogenic diet improves severe mental illness

2024-04-01

For people living with serious mental illness like schizophrenia or bipolar disorder, standard treatment with antipsychotic medications can be a double-edged sword. While these drugs help regulate brain chemistry, they often cause metabolic side effects such as insulin resistance and obesity, which are distressing enough that many patients stop taking the medications. Now, a pilot study led by Stanford Medicine researchers has found that a ketogenic diet not only restores metabolic health in these patients as they continue their medications, but it further improves their psychiatric conditions. The results, published March 27 in Psychiatry Research, suggest that a dietary intervention ...

Physics-based predictive tool will speed up battery and superconductor research

2024-04-01

Tokyo, Japan – From lithium-ion batteries to next-generation superconductors, the functionality of many modern, advanced technologies depends on the physical property known as intercalation. Unfortunately, it's difficult to identify in advance which of the many possible intercalated materials are stable, which necessitates a lot of trial-and-error lab work in product development. Now, in a study recently published in ACS Physical Chemistry Au, researchers from the Institute of Industrial Science, ...

New advance against a form of heart failure prevalent in men

2024-04-01

University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that contributes to the greater incidence of heart failure in men. Y chromosome loss in men occurs progressively throughout life and can be detected in approximately 40% of 70-year-old men. UVA’s Kenneth Walsh, PhD, discovered in 2022 that this loss can contribute to heart muscle scarring and lead to deadly heart failure. (That finding was the first to directly link Y chromosome loss to a specific harm to men’s health; Y chromosome loss is increasingly thought ...

Canton wins Wayne Bardin International Travel Award

2024-04-01

WASHINGTON—The Endocrine Society selected Ana Canton, M.D., Ph.D., as the recipient of its 2024 C. Wayne Bardin, MD, International Travel Award for her outstanding ENDO abstract and her research contributions to the care of patients with pediatric endocrine disorders. The C. Wayne Bardin, MD, International Travel Award was created in honor of Past President Wayne Bardin, who made remarkable research contributions to both reproductive physiology and contraception throughout his long career. As the winner, ...

Memorial Sloan Kettering Cancer Center experts to present leading-edge research at the American Association for Cancer Research Annual Meeting 2024

2024-04-01

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California. MSK experts will present significant research and will be available to comment on topics including cancer metastasis, immunology, molecular biology and genetics, and early drug development. Vinod Balachandran, MD, will present updates on personalized RNA neoantigen vaccines in pancreatic cancer ...

LAST 30 PRESS RELEASES:

Dual-target CAR T cell therapy slows growth of aggressive brain cancer

Adding immune checkpoint inhibitor to standard chemotherapy regimen improves outcomes in stage 3 colon cancer, study finds

Diet influences survival after stage iii colon cancer, Dana-Farber study finds

Switch to experimental drug after liquid biopsy detection of breast cancer recurrence improves outcomes

Alliance presents results from phase III ATOMIC trial combining atezolizumab with chemotherapy for patients with stage III dMMR colon cancer at ASCO 2025